3:15 pm From Steatosis to Fibrosis & Beyond –Non-Invasive Imaging in MASLD/MASH

  • Understanding the complexity of MASLD/MASH and its downstream consequences
  • New advances in clinical non-invasive imaging of fibrosis and cirrhosis
  • How insights from multiple biomarkers can shape and accelerate decision-making in drug development